Evaluation of the Effect of Dietary PI and TAC on the Outcome of Pregnancy in In Vitro Fertilization Treatment
1 other identifier
observational
280
1 country
1
Brief Summary
The aim of this study is to determine the relationship between dietary total antioxidant capacity, phytochemical index, inflammatory index, dietary polyphenol intake and ongoing pregnancy outcome in couples receiving IVF treatment. In this context, the objectives are: Determining the relationship between diet's antioxidant capacity, phytochemical index, inflammatory index, and dietary polyphenol intake and ongoing pregnancy outcome, Determining the relationship between total serum antioxidant capacity, serum oxidant capacity and CRP levels and ongoing pregnancy outcome, It is the determination of the relationship between body composition and ongoing pregnancy. With this study, it is aimed to obtain reliable data on the effects of diet's antioxidant capacity, phytochemical index and dietary polyphenol intake and inflammatory index on reproductive functions. In this way, it is thought that nutritional recommendations that can be given to patients who will undergo IVF treatment before treatment will be developed. In this study, which is a first in terms of examining many parameters related to diets of women and men, it will be evaluated whether the parameters to be examined are effective in IVF cycles. The aims, objectives and hypotheses the researchers put forward within the scope of the study have not been studied extensively before. If the planned project is carried out successfully, new nutritional approaches will be paved in in-vitro fertilization treatment, and it will be possible to contribute to reducing the financial burden of the treatment. In addition, an important step will be taken to increase the total fertility rate (number of children per woman) within the scope of the 11th Development Plan (2019-2023). It also conforms to the 3rd Sustainable Development Goals, "healthy and quality life" (UNDP Turkey 2018)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2021
CompletedFirst Submitted
Initial submission to the registry
May 17, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2024
CompletedFebruary 26, 2025
November 1, 2024
3 years
May 17, 2023
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ongoing pregnancy
"Ongoing pregnancy" is a term used in reproductive medicine to describe a pregnancy that has progressed beyond the early stages and is continuing to develop with a viable fetal heartbeat. Ongoing pregnancy is typically confirmed by ultrasound examination after the gestational age of 12 weeks. In assisted reproductive technology (ART) cycles, ongoing pregnancy rate is an important outcome measure used to assess the success of the procedure, as it reflects the number of pregnancies that have the potential to result in live births.
1 year
Secondary Outcomes (1)
Clinical pregnancy
1 year
Eligibility Criteria
Couples who apply to the IVF unit and meet the following criteria will be included.
You may qualify if:
- Females \<41 years
- Males \< 55 years
- BKI ≤ 32 kg/m2
You may not qualify if:
- Smoking cigarettes
- Chronic and inflammatory diseases
- Dietary changes in last 6 months
- Using antioxidant supplements
- Females diagnosed with infertility for anatomical reasons, endometriosis, tubal factor, or low ovarian reserve
- Males diagnosed with azospermia
- Couples who have had more than two failed cycles
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe
Ankara, Altındag, 06100, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assisstant
Study Record Dates
First Submitted
May 17, 2023
First Posted
May 31, 2023
Study Start
February 15, 2021
Primary Completion
February 15, 2024
Study Completion
April 15, 2024
Last Updated
February 26, 2025
Record last verified: 2024-11